Authors:
Blaney, FE
Raveglia, LF
Artico, M
Cavagnera, S
Dartois, C
Farina, C
Grugni, M
Gagliardi, S
Luttmann, MA
Martinelli, M
Nadler, GMMG
Parini, C
Petrillo, P
Sarau, HM
Scheideler, MA
Hay, DWP
Giardina, GAM
Citation: Fe. Blaney et al., Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity andselectivity in quinoline tachykinin receptor antagonists, J MED CHEM, 44(11), 2001, pp. 1675-1689
Authors:
Sarau, HM
Feild, JA
Ames, RS
Foley, JJ
Nuthulaganti, P
Schmidt, DB
Buckley, PT
Elshourbagy, NA
Brawner, ME
Luttmann, MA
Giardina, GAM
Hay, DWP
Citation: Hm. Sarau et al., Molecular and pharmacological characterization of the murine tachykinin NK3 receptor, EUR J PHARM, 413(2-3), 2001, pp. 143-150
Authors:
Hay, DWP
Douglas, SA
Ao, ZH
Moesker, RM
Self, GJ
Rigby, PJ
Luttmann, MA
Goldie, RG
Citation: Dwp. Hay et al., Differential modulation of endothelin ligand-induced contraction in isolated tracheae from endothelin B (ETB) receptor knockout mice, BR J PHARM, 132(8), 2001, pp. 1905-1915
Authors:
Bochnowicz, S
Osborn, RR
Luttmann, MA
Louden, C
Hart, T
Hay, DWP
Underwood, DC
Citation: S. Bochnowicz et al., Differences in time-related cardiopulmonary responses to hypoxia in three rat strains, CLIN EXP HY, 22(5), 2000, pp. 471-492
Authors:
Ammit, AJ
Hoffman, RK
Amrani, Y
Lazaar, AL
Hay, DWP
Torphy, TJ
Penn, RB
Panettieri, RA
Citation: Aj. Ammit et al., Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells - Modulation by cyclic adenosine monophosphate, AM J RESP C, 23(6), 2000, pp. 794-802
Authors:
Underwood, DC
Osborn, RR
Bochnowicz, S
Webb, EF
Rieman, DJ
Lee, JC
Romanic, AM
Adams, JL
Hay, DWP
Griswold, DE
Citation: Dc. Underwood et al., SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung, AM J P-LUNG, 279(5), 2000, pp. L895-L902
Authors:
Griswold, DE
Douglas, SA
Martin, LD
Davis, TG
Davis, L
Ao, ZH
Luttmann, MA
Pullen, M
Nambi, P
Hay, DWP
Ohlstein, EH
Citation: De. Griswold et al., Targeted disruption of the endothelin-B-receptor gene attenuates inflammatory nociception and cutaneous inflammation in mice, J CARDIO PH, 36, 2000, pp. S78-S81
Authors:
Sarau, HM
Mooney, JL
Schmidt, DB
Foley, JJ
Buckley, PT
Giardina, GAM
Wang, DY
Lee, JA
Hay, DWP
Citation: Hm. Sarau et al., Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin, MOLEC PHARM, 58(3), 2000, pp. 552-559
Authors:
Ruggieri, MR
Filer-Maerten, S
Hieble, JP
Hay, DWP
Citation: Mr. Ruggieri et al., Role of neurokinin receptors in the behavioral effect of intravesical antigen infusion in guinea pig bladder, J UROL, 164(1), 2000, pp. 197
Authors:
Sarau, HM
Griswold, DE
Bush, B
Potts, W
Sandhu, P
Lundberg, D
Foley, JJ
Schmidt, DB
Webb, EF
Martin, LD
Legos, JJ
Whitmore, RG
Barone, FC
Medhurst, AD
Luttmann, MA
Giardina, GAM
Hay, DWP
Citation: Hm. Sarau et al., Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist, J PHARM EXP, 295(1), 2000, pp. 373-381
Authors:
Sarau, HM
Foley, JJ
Schmidt, DB
Martin, LD
Webb, EF
Tzimas, MN
Breton, JJ
Chabot-Fletcher, M
Underwood, DC
Hay, DWP
Kingsbury, WD
Chambers, PA
Pendrak, I
Jakas, DR
Sathe, GM
Van Horn, S
Daines, RA
Griswold, DE
Citation: Hm. Sarau et al., In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity, PROS LEUK E, 61(1), 1999, pp. 55-64
Authors:
Raveglia, LF
Vitali, M
Artico, M
Graziani, D
Hay, DWP
Luttmann, MA
Mena, R
Pifferi, G
Giardina, GAM
Citation: Lf. Raveglia et al., Investigation of SAR requirements of SR 142801 through an indexed combinatorial library in solution, EUR J MED C, 34(10), 1999, pp. 825-835
Authors:
Ames, RS
Sarau, HM
Chambers, JK
Willette, RN
Alyar, NV
Romanic, AM
Louden, CS
Foley, JJ
Sauermelch, CF
Coatney, RW
Ao, ZH
Disa, J
Holmes, SD
Stadel, JM
Martin, JD
Liu, WS
Glover, GI
Wilson, S
McNulty, DE
Ellis, CE
Elshourbagy, NA
Shabon, U
Trill, JJ
Hay, DWP
Ohlstein, EH
Bergsma, DJ
Douglas, SA
Citation: Rs. Ames et al., Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 (vol 401, pg 282, 1999), NATURE, 402(6764), 1999, pp. 898-898
Authors:
Ames, RS
Sarau, HM
Chambers, JK
Willette, RN
Alyar, NV
Romanic, AM
Louden, CS
Foley, JJ
Sauermelch, CF
Coatney, RW
Ao, ZH
Disa, J
Holmes, SD
Stadel, JM
Martin, JD
Liu, WS
Glover, GI
Wilson, S
McNulty, DE
Ellis, CE
Elshourbagy, NA
Shabon, U
Trill, JJ
Hay, DWP
Ohlstein, EH
Bergsma, DJ
Douglas, SA
Citation: Rs. Ames et al., Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14, NATURE, 401(6750), 1999, pp. 282-286
Authors:
Sarau, HM
Ames, RS
Chambers, J
Ellis, C
Elshourbagy, N
Foley, JJ
Schmidt, DB
Muccitelli, RM
Jenkins, O
Murdock, PR
Herrity, NC
Halsey, W
Sathe, G
Muir, AI
Nuthulaganti, P
Dytko, GM
Buckley, PT
Wilson, S
Bergsma, DJ
Hay, DWP
Citation: Hm. Sarau et al., Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor, MOLEC PHARM, 56(3), 1999, pp. 657-663